Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma
Clinical trial NCT07750067 · RECRUITING
Trial details
- NCT number
- NCT07750067
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2030-07-28
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.